Login / Signup

The incidence and characteristics of VTE within 100 days of CAR T-cell therapy.

Kelly J GaffneyMary McGannJames A DavisKathy H EdwardsHamza Hashmi
Published in: Annals of hematology (2023)
Keyphrases
  • cell therapy
  • venous thromboembolism
  • stem cells
  • risk factors
  • mesenchymal stem cells